查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
藥品製造市場規模、佔有率和趨勢分析報告：2023-2030年途徑、按分子類型、按藥物開發類型、按銷售管道、按年齡層、按劑型、按地區和按細分市場預測
市場調查報告書
商品編碼
1321439

藥品製造市場規模、佔有率和趨勢分析報告：2023-2030年途徑、按分子類型、按藥物開發類型、按銷售管道、按年齡層、按劑型、按地區和按細分市場預測

Pharmaceutical Manufacturing Market Size, Share & Trends Analysis Report By Route of Administration, By Molecule Type, By Drug Development Type, By Sales Channel, By Age Group, By Formulation, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 170 Pages | 商品交期: 2-10個工作天內

價格

藥品製造市場的成長與趨勢

Grand View Research 的最新報告顯示，到2030年，全球藥品製造市場預計將達到 9,299 億美元。

預計2023年至2030年年複合成長率為7.63%。由於技術進步、成本效益方法和投資增加，製藥業經歷了重大轉型。這些要素對市場成長有正面影響。機器人技術和人工智慧 (AI) 的引進在減少製造車間的停機時間和最大限度地減少產品浪費方面發揮關鍵作用。這些技術的結合顯著提高了藥品製造流程的效率和生產率。

此外，傳統的開放式轉移製造方法被拋棄式解決方案所取代，簡化了操作並降低了污染風險。此外，產業內也發生了向整合、智慧、資料豐富和無紙化營運的重大轉變。這項轉變帶來了無錯誤且準確的生產流程，生產出高品質的藥品。市場的這些持續進步大幅促進了藥品製造的進步。個人化醫療的發展徹底改變了醫療保健領域，為針對各種健康狀況提供了新的機會，並為以患者為中心的模式鋪平了道路。

因此，生產從大批量轉向小批量生產，以適應複雜藥物的開發和針對個別患者的個體化治療。這種變革性的轉變迫使製造商重新構想他們的供應鏈，以適應以病人為中心的醫療保健系統。所有這些要素都在推動預測期內藥品製造市場的成長。此外，製藥業的領先公司採取策略性舉措，以提高其在市場上的影響力並獲得競爭優勢。這些大公司積極參與各種活動，包括產品開發、聯盟/合作夥伴模式、合約、業務擴張和併購策略。

這些措施也目的是加強產品系列滿足對藥品不斷成長的需求。例如，2022年 4月，Ferring Pharmaceuticals在印度海得拉巴開設了一家整合製造和研發 (R&D) 工廠。該設施凸顯了Ferring致力於擴大其業務和能力的承諾。該工廠的研發部門致力於包裝開發、配方開發和分析開發等領域。透過在這些領域的投資，Ferring Pharmaceuticals目的是加強其產品供應並滿足市場不斷變化的需求。

藥品製造市場報告亮點

  • 2022年，常規藥物（小分子）領域銷售額佔比最高，超過54.9%。這是由於小分子產品的現成性和高市場滲透率。
  • 2022年，外包部門佔市佔率超過53%。與外包業務相關的多項好處預計將在未來幾年推動該行業以有利的速度成長。
  • 從收入來看，錠劑設備領域在2022年佔據市場主導地位，佔有率超過26.08%。這是由於錠劑產品和類型的廣泛使用，包括薄膜片劑、發泡片劑、崩解錠和口腔崩解片劑。
  • 2022年，口服藥物細分市場以超過58%的佔有率引領全球市場。口服劑型價格實惠、易於製造且對患者友善。
  • 2022年，處方藥細分市場的收入佔有率最大，為83.76%，並且由於全球處方藥支出的增加，在預測期內將以穩定的年複合成長率進一步擴大。
  • 由於該地區建立了大量的戰略醫藥聯盟，尤其是在成熟公司和年輕公司之間，北美在2022年佔據了市場主導地位並佔據了重要的收入佔有率。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 藥品製造市場變數、趨勢、範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附屬市場預測
  • 普及和成長前景圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 藥品製造市場分析工具
    • 產業分析-波特
    • PESTEL分析

第4章 藥品製造：分子類型的估計與趨勢分析

  • 定義和範圍
  • 市場佔有率，2022/2030
  • 細分儀表板
  • 全球市場預測
  • 2018-2030年市場規模、預測與趨勢分析
    • 生物製劑和生物相似藥（大分子）
    • 常規藥物（小分子）

第5章 藥品製造：藥品開發類型估算及趨勢分析

  • 定義和範圍
  • 市場佔有率，2022/2030
  • 細分儀表板
  • 全球市場預測
  • 2018-2030年市場規模、預測與趨勢分析
    • 公司內部
    • 外包

第6章 藥品製造：劑型的估算與趨勢分析

  • 定義和範圍
  • 市場佔有率，2022/2030
  • 細分儀表板
  • 全球市場預測
  • 2018-2030年市場規模、預測與趨勢分析
    • 錠劑
    • 膠囊
    • 注射
    • 噴劑
    • 懸浮液
    • 粉末
    • 其他

第7章 藥品生產：給藥途徑估算及趨勢分析

  • 定義和範圍
  • 市場佔有率，2022/2030
  • 細分儀表板
  • 全球市場預測
  • 2018-2030年市場規模、預測與趨勢分析
    • 口服
    • 外用
    • 非經口
    • 吸入
    • 其他

第8章 藥品製造：治療領域的估計與趨勢分析

  • 定義和範圍
  • 市場佔有率，2022/2030
  • 細分儀表板
  • 全球市場預測
  • 2018-2030年市場規模、預測與趨勢分析
    • 心血管疾病
    • 疼痛
    • 糖尿病
    • 癌症
    • 呼吸系統疾病
    • 其他

第9章 藥品製造：處方估算與趨勢分析

  • 定義和範圍
  • 市場佔有率，2022/2030
  • 細分儀表板
  • 全球市場預測
  • 2018-2030年市場規模、預測與趨勢分析
    • 處方藥
    • 非處方藥 (OTC)

第10章 藥品製造：年齡層估計/趨勢分析

  • 定義和範圍
  • 市場佔有率，2022/2030
  • 細分儀表板
  • 全球市場預測
  • 2018-2030年市場規模、預測與趨勢分析
    • 兒童和青少年
    • 成人
    • 對於老年人

第11章 藥品製造：銷售管道估算/趨勢分析

  • 定義和範圍
  • 市場佔有率，2022/2030
  • 細分儀表板
  • 全球市場預測
  • 2018-2030年市場規模、預測與趨勢分析
    • 零售
    • 非零售

第12章 藥品製造市場：區域估計與趨勢分析

  • 2022年及2030年區域市佔率分析
  • 區域市場儀表板
  • 全球區域市場概況
  • 2021年區域市場佔有率和主要企業
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 要素因素（政治/法律、經濟/技術）進行 SWOT 分析
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 2018-2030年市場規模、預測、數量與趨勢分析：
  • 北美洲
    • SWOT分析
    • 2018年至2030年北美市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • SWOT分析
    • 2018年至2030年歐洲市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • SWOT分析
    • 2018-2030年亞太市場估計與預測
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • SWOT分析
    • 2018-2030年拉丁美洲市場估計與預測
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東、非洲
    • SWOT分析
    • 2018年至2030年 MEA 市場估計與預測
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第13章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭分類
    • 創新者
  • 供應商形勢
    • F. Hoffmann-La Roche Ltd.
    • Novartis AG
    • GlaxoSmithKline plc
    • Pfizer, Inc.
    • Merck &Co., Inc.
    • AstraZeneca
    • Johnson &Johnson Services, Inc.
    • Sanofi SA
    • Eli Lilly and Company
    • AbbVie, Inc.
    • Thermo Fisher Scientific, Inc.
    • Wuxi Apptec
    • Samsung Biologics
    • FUJIFILM Diosynth Biotechnologies USA, Inc.
    • Lonza
    • Catalent Pharma Solutions
    • Jubilant Pharmova Limited
Product Code: GVR-4-68039-014-2

Pharmaceutical Manufacturing Market Growth & Trends

The global pharmaceutical manufacturing market size is expected to reach USD 929.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 7.63% from 2023 to 2030. The pharmaceutical industry has undergone significant transformations as a result of technological advancements, cost-effective methods, and increased investments. These factors have had a positive impact on the growth of the market. The implementation of robotic technology and Artificial Intelligence (AI) has played a crucial role in reducing manufacturing floor downtime and minimizing product waste. By incorporating these technologies, efficiency, and productivity in pharmaceutical manufacturing processes have been greatly improved.

In addition, traditional open-transfer manufacturing methods have been replaced by the adoption of single-use disposable solutions, leading to streamlined operations and reduced risks of contamination. Moreover, there has been a notable shift toward integrated, smart, and data-rich paperless operations within the industry. This transition has resulted in error-free and precise production processes, ensuring the production of high-quality pharmaceutical products. These ongoing advancements in the market have significantly contributed to the progress of drug manufacturing. The development of personalized medicine has brought about a revolution in the healthcare sector, offering new opportunities to target various health conditions and paving the way for patient-centric models.

Consequently, there has been a shift from large-scale production to smaller batches to cater to the development of complex medicines and personalized treatments tailored to individual patients. This transformative shift has prompted manufacturers to restructure their supply chains in alignment with the patient-centric healthcare system. All such factors propel pharmaceutical manufacturing market growth over the forecast period. Furthermore, leading companies in the pharmaceutical industry have taken strategic initiatives to enhance their market presence and gain a competitive advantage. These key players actively engage in various activities, such as product development, collaboration & partnership models, agreements, business expansion, and merger & acquisition strategies.

These initiatives are also aimed at strengthening their product portfolios and meeting the growing demand for pharmaceutical products. For instance, in April 2022, Ferring Pharmaceuticals inaugurated an integrated manufacturing and research and development (R&D) facility in Hyderabad, India. This facility underscores Ferring's commitment to expanding its operations and capabilities. The R&D division of the facility focuses on areas, such as packaging development, formulation development, and analytical development. Ferring Pharmaceuticals aims to enhance its product offerings and meet the evolving needs of the market by investing in these areas.

Pharmaceutical Manufacturing Market Report Highlights

  • In 2022, the conventional drugs (small molecules) segment accounted for the highest revenue share of over 54.9%. This is attributed to the easy availability of small molecules products, with high market penetration
  • The outsourcing segment dominated the market in 2022 with a revenue share of over 53%. Several benefits associated with outsourcing operations are expected to drive the segment growth at a lucrative pace over the coming years
  • In terms of revenue, the tablets segment dominated the market with a share of over 26.08 % in 2022. This is due to the wide availability of tablet-based products and types, such as film and enteric-coated, effervescent, and orally disintegrating tablets
  • The oral segment led the global market with a share of more than 58% in 2022. Oral dosage forms are affordable, easy to manufacture, and patient-friendly
  • The prescription medicines segment accounted for the maximum revenue share of 83.76% in 2022 and will expand further at a steady CAGR over the forecast period due to the growing prescription drug expenditures across the globe
  • North America dominated the market and accounted for a significant revenue share in 2022 due to a large number of strategic pharma partnerships, especially among the well-established and early-stage companies, in this region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Molecule Type
    • 1.2.2. Drug Development Type
    • 1.2.3. Formulation
    • 1.2.4. Routes of Administration
    • 1.2.5. Therapy Area
    • 1.2.6. Prescription
    • 1.2.7. Age Group
    • 1.2.8. Sales Channel
  • 1.3. Regional Scope
  • 1.4. Estimates and Forecast Timeline
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased database
    • 1.6.2. GVR's internal database
    • 1.6.3. Secondary sources
    • 1.6.4. Primary research
    • 1.6.5. Details of primary research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data analysis models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
      • 1.9.1.1. Commodity flow analysis (Model 1)
      • 1.9.1.2. Approach 1: Commodity flow approach
      • 1.9.1.3. Volume price analysis (Model 2)
      • 1.9.1.4. Approach 2: Volume price analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Primary Sources
  • 1.12. Objectives
    • 1.12.1. Objective 1
    • 1.12.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Molecule Type outlook
    • 2.2.2. Drug Development Type outlook
    • 2.2.3. Formulation outlook
    • 2.2.4. Route of Administration outlook
    • 2.2.5. Therapy Area outlook
    • 2.2.6. Prescription outlook
    • 2.2.7. Age Group outlook
    • 2.2.8. Sales Channel outlook
    • 2.2.9. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Pharmaceutical Manufacturing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Rise in pharmaceutical R&D spending
      • 3.3.1.2. Rise in focus toward healthcare needs in emerging nations
      • 3.3.1.3. Technological advancements
      • 3.3.1.4. Increase in geriatric population and incidence of chronic disorders
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. Patent expiration of most profitable drugs
      • 3.3.2.2. Pricing pressures on bio/pharmaceutical companies
  • 3.4. Pharmaceutical manufacturing Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Pharmaceutical Manufacturing: Molecule Type Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Biologics & Biosimilars (Large Molecules)
    • 4.1.2. Conventional Drugs (Small Molecules)
  • 4.2. Molecule Type Market Share, 2022 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Pharmaceutical Manufacturing Market by Molecule Type Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Biologics & Biosimilars (Large Molecules)
      • 4.5.1.1. Biologics & Biosimilars (Large Molecules) market estimates and forecast 2018 to 2030 (USD Billion)
      • 4.5.1.2. Monoclonal Antibodies
      • 4.5.1.2.1. Monoclonal Antibodies market estimates and forecast 2018 to 2030 (USD Billion)
      • 4.5.1.3. Vaccines
      • 4.5.1.3.1. Vaccines market estimates and forecast 2018 to 2030 (USD Billion)
      • 4.5.1.4. Cell & Gene Therapy
      • 4.5.1.4.1. Cell & Gene Therapy market estimates and forecast 2018 to 2030 (USD Billion)
      • 4.5.1.5. Others
      • 4.5.1.5.1. Others market estimates and forecast 2018 to 2030 (USD Billion)
    • 4.5.2. Conventional Drugs (Small Molecules)
      • 4.5.2.1. Conventional Drugs (Small Molecules) market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 5. Pharmaceutical Manufacturing: Drug Development Type Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. In-house
    • 5.1.2. Outsource
  • 5.2. Drug Development Type Market Share, 2022 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Microneedle Drug Delivery Systems Market by Drug Development Type Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030for the following
    • 5.5.1. In-house
      • 5.5.1.1. In-house market estimates and forecast 2018 to 2030 (USD Billion)
    • 5.5.2. Outsource
      • 5.5.2.1. Outsource market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 6. Pharmaceutical Manufacturing: Formulation Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Tablets
    • 6.1.2. Capsules
    • 6.1.3. Injectable
    • 6.1.4. Sprays
    • 6.1.5. Suspensions
    • 6.1.6. Powders
    • 6.1.7. Others
  • 6.2. Formulation Market Share, 2022 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Pharmaceutical Manufacturing Market by Formulation Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Tablets
      • 6.5.1.1. Tablets market estimates and forecast 2018 to 2030 (USD Billion)
    • 6.5.2. Capsules
      • 6.5.2.1. Capsules market estimates and forecast 2018 to 2030 (USD Billion)
    • 6.5.3. Injectable
      • 6.5.3.1. Injectable market estimates and forecast 2018 to 2030 (USD Billion)
    • 6.5.4. Sprays
      • 6.5.4.1. Sprays market estimates and forecast 2018 to 2030 (USD Billion)
    • 6.5.5. Suspensions
      • 6.5.5.1. Suspensions market estimates and forecast 2018 to 2030 (USD Billion)
    • 6.5.6. Powders
      • 6.5.6.1. Powders market estimates and forecast 2018 to 2030 (USD Billion)
    • 6.5.7. Others
      • 6.5.7.1. Others market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 7. Pharmaceutical Manufacturing: Route of Administration Estimates & Trend Analysis

  • 7.1. Definitions and Scope
    • 7.1.1. Oral
    • 7.1.2. Topical
    • 7.1.3. Parenteral
    • 7.1.4. Inhalations
    • 7.1.5. Others
  • 7.2. Route of Administration Market Share, 2022 & 2030
  • 7.3. Segment Dashboard
  • 7.4. Global Pharmaceutical Manufacturing Market by Route of Administration Outlook
  • 7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.5.1. Oral
      • 7.5.1.1. Oral market estimates and forecast 2018 to 2030 (USD Billion)
    • 7.5.2. Topical
      • 7.5.2.1. Topical market estimates and forecast 2018 to 2030 (USD Billion)
    • 7.5.3. Parenteral
      • 7.5.3.1. Parenteral market estimates and forecast 2018 to 2030 (USD Billion)
    • 7.5.4. Inhalations
      • 7.5.4.1. Inhalations market estimates and forecast 2018 to 2030 (USD Billion)
    • 7.5.5. Others
      • 7.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 8. Pharmaceutical Manufacturing: Therapy Area Estimates & Trend Analysis

  • 8.1. Definitions and Scope
    • 8.1.1. Cardiovascular diseases
    • 8.1.2. Pain
    • 8.1.3. Diabetes
    • 8.1.4. Cancer
    • 8.1.5. Respiratory diseases
    • 8.1.6. Others
  • 8.2. Therapy Area Market Share, 2022 & 2030
  • 8.3. Segment Dashboard
  • 8.4. Global Pharmaceutical Manufacturing Market by Therapy Area Outlook
  • 8.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 8.5.1. Cardiovascular diseases
      • 8.5.1.1. Cardiovascular diseases market estimates and forecast 2018 to 2030 (USD Billion)
    • 8.5.2. Pain
      • 8.5.2.1. Pain market estimates and forecast 2018 to 2030 (USD Billion)
    • 8.5.3. Diabetes
      • 8.5.3.1. Diabetes market estimates and forecast 2018 to 2030 (USD Billion)
    • 8.5.4. Cancer
      • 8.5.4.1. Cancer market estimates and forecast 2018 to 2030 (USD Billion)
    • 8.5.5. Respiratory diseases
      • 8.5.5.1. Respiratory diseases market estimates and forecast 2018 to 2030 (USD Billion)
    • 8.5.6. Others
      • 8.5.6.1. Others market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 9. Pharmaceutical Manufacturing: Prescription Estimates & Trend Analysis

  • 9.1. Definitions and Scope
    • 9.1.1. Prescription Medicines
    • 9.1.2. Over-the-counter (OTC) medicines
  • 9.2. Prescription Market Share, 2022 & 2030
  • 9.3. Segment Dashboard
  • 9.4. Global Pharmaceutical Manufacturing Market by Prescription Outlook
  • 9.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 9.5.1. Prescription Medicines
      • 9.5.1.1. Prescription Medicines market estimates and forecast 2018 to 2030 (USD Billion)
    • 9.5.2. Over-the-counter (OTC) medicines
      • 9.5.2.1. Over-the-counter (OTC) medicines market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 10. Pharmaceutical Manufacturing: Age Group Estimates & Trend Analysis

  • 10.1. Definitions and Scope
    • 10.1.1. Children & Adolescents
    • 10.1.2. Adults
    • 10.1.3. Geriatric
  • 10.2. Age Group Market Share, 2022 & 2030
  • 10.3. Segment Dashboard
  • 10.4. Global Pharmaceutical Manufacturing Market by Age Group Outlook
  • 10.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030for the following
    • 10.5.1. Children & Adolescents
      • 10.5.1.1. Children & Adolescents market estimates and forecast 2018 to 2030 (USD Billion)
    • 10.5.2. Adults
      • 10.5.2.1. Adults market estimates and forecast 2018 to 2030 (USD Billion)
    • 10.5.3. Geriatric
      • 10.5.3.1. Geriatric market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 11. Pharmaceutical Manufacturing: Sales Channel Estimates & Trend Analysis

  • 11.1. Definitions and Scope
    • 11.1.1. Retail
    • 11.1.2. Non-retail
  • 11.2. Sales Channel Market Share, 2022 & 2030
  • 11.3. Segment Dashboard
  • 11.4. Global Pharmaceutical Manufacturing Market by Sales Channel Outlook
  • 11.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 11.5.1. Retail
      • 11.5.1.1. Retail market estimates and forecast 2018 to 2030 (USD Billion)
    • 11.5.2. Non-retail
      • 11.5.2.1. Non-retail market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 12. Pharmaceutical Manufacturing Market: Regional Estimates & Trend Analysis

  • 12.1. Regional market share analysis, 2022 & 2030
  • 12.2. Regional Market Dashboard
  • 12.3. Global Regional Market Snapshot
  • 12.4. Regional Market Share and Leading Players, 2021
    • 12.4.1. North America
    • 12.4.2. Europe
    • 12.4.3. Asia Pacific
    • 12.4.4. Latin America
    • 12.4.5. Middle East and Africa
  • 12.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 12.5.1. North America
    • 12.5.2. Europe
    • 12.5.3. Asia Pacific
    • 12.5.4. Latin America
    • 12.5.5. Middle East and Africa
  • 12.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
  • 12.7. North America
    • 12.7.1. SWOT Analysis
    • 12.7.2. North America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 12.7.3. U.S.
      • 12.7.3.1. Key Country Dynamics
      • 12.7.3.2. Target Disease Prevalence
      • 12.7.3.3. Competitive Scenario
      • 12.7.3.4. Regulatory Framework
      • 12.7.3.5. U.S. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 12.7.4. Canada
      • 12.7.4.1. Key Country Dynamics
      • 12.7.4.2. Target Disease Prevalence
      • 12.7.4.3. Competitive Scenario
      • 12.7.4.4. Regulatory Framework
      • 12.7.4.5. Canada Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 12.8. Europe
    • 12.8.1. SWOT Analysis
    • 12.8.2. Europe Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 12.8.3. UK
      • 12.8.3.1. Key Country Dynamics
      • 12.8.3.2. Target Disease Prevalence
      • 12.8.3.3. Competitive Scenario
      • 12.8.3.4. Regulatory Framework
      • 12.8.3.5. UK Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 12.8.4. Germany
      • 12.8.4.1. Key Country Dynamics
      • 12.8.4.2. Target Disease Prevalence
      • 12.8.4.3. Competitive Scenario
      • 12.8.4.4. Regulatory Framework
      • 12.8.4.5. Germany Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 12.8.5. France
      • 12.8.5.1. Key Country Dynamics
      • 12.8.5.2. Target Disease Prevalence
      • 12.8.5.3. Competitive Scenario
      • 12.8.5.4. Regulatory Framework
      • 12.8.5.5. France Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 12.8.6. Italy
      • 12.8.6.1. Key Country Dynamics
      • 12.8.6.2. Target Disease Prevalence
      • 12.8.6.3. Competitive Scenario
      • 12.8.6.4. Regulatory Framework
      • 12.8.6.5. Italy Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 12.8.7. Spain
      • 12.8.7.1. Key Country Dynamics
      • 12.8.7.2. Target Disease Prevalence
      • 12.8.7.3. Competitive Scenario
      • 12.8.7.4. Regulatory Framework
      • 12.8.7.5. Spain Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 12.8.8. Denmark
      • 12.8.8.1. Key Country Dynamics
      • 12.8.8.2. Target Disease Prevalence
      • 12.8.8.3. Competitive Scenario
      • 12.8.8.4. Regulatory Framework
      • 12.8.8.5. Denmark Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 12.8.9. Sweden
      • 12.8.9.1. Key Country Dynamics
      • 12.8.9.2. Target Disease Prevalence
      • 12.8.9.3. Competitive Scenario
      • 12.8.9.4. Regulatory Framework
      • 12.8.9.5. Sweden Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 12.8.10. Norway
      • 12.8.10.1. Key Country Dynamics
      • 12.8.10.2. Target Disease Prevalence
      • 12.8.10.3. Competitive Scenario
      • 12.8.10.4. Regulatory Framework
      • 12.8.10.5. Norway Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 12.9. Asia Pacific
    • 12.9.1. SWOT Analysis
    • 12.9.2. Asia Pacific Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 12.9.3. China
      • 12.9.3.1. Key Country Dynamics
      • 12.9.3.2. Target Disease Prevalence
      • 12.9.3.3. Competitive Scenario
      • 12.9.3.4. Regulatory Framework
      • 12.9.3.5. China Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 12.9.4. Japan
      • 12.9.4.1. Key Country Dynamics
      • 12.9.4.2. Target Disease Prevalence
      • 12.9.4.3. Competitive Scenario
      • 12.9.4.4. Regulatory Framework
      • 12.9.4.5. Japan Market estimates and forecast, 2018 - 2030 (Volume, Thousand)
    • 12.9.5. India
      • 12.9.5.1. Key Country Dynamics
      • 12.9.5.2. Target Disease Prevalence
      • 12.9.5.3. Competitive Scenario
      • 12.9.5.4. Regulatory Framework
      • 12.9.5.5. India Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 12.9.6. Australia
      • 12.9.6.1. Key Country Dynamics
      • 12.9.6.2. Target Disease Prevalence
      • 12.9.6.3. Competitive Scenario
      • 12.9.6.4. Regulatory Framework
      • 12.9.6.5. Australia Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 12.9.7. Thailand
      • 12.9.7.1. Key Country Dynamics
      • 12.9.7.2. Target Disease Prevalence
      • 12.9.7.3. Competitive Scenario
      • 12.9.7.4. Regulatory Framework
      • 12.9.7.5. Thailand Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 12.9.8. South Korea
      • 12.9.8.1. Key Country Dynamics
      • 12.9.8.2. Target Disease Prevalence
      • 12.9.8.3. Competitive Scenario
      • 12.9.8.4. Regulatory Framework
      • 12.9.8.5. South Korea Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 12.10. Latin America
    • 12.10.1. SWOT Analysis
    • 12.10.2. Latin America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 12.10.3. Brazil
      • 12.10.3.1. Key Country Dynamics
      • 12.10.3.2. Target Disease Prevalence
      • 12.10.3.3. Competitive Scenario
      • 12.10.3.4. Regulatory Framework
      • 12.10.3.5. Brazil Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 12.10.4. Mexico
      • 12.10.4.1. Key Country Dynamics
      • 12.10.4.2. Target Disease Prevalence
      • 12.10.4.3. Competitive Scenario
      • 12.10.4.4. Regulatory Framework
      • 12.10.4.5. Mexico Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 12.10.5. Argentina
      • 12.10.5.1. Key Country Dynamics
      • 12.10.5.2. Target Disease Prevalence
      • 12.10.5.3. Competitive Scenario
      • 12.10.5.4. Regulatory Framework
      • 12.10.5.5. Argentina Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 12.11. MEA
    • 12.11.1. SWOT Analysis
    • 12.11.2. MEA Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 12.11.3. Saudi Arabia
      • 12.11.3.1. Key Country Dynamics
      • 12.11.3.2. Target Disease Prevalence
      • 12.11.3.3. Competitive Scenario
      • 12.11.3.4. Regulatory Framework
      • 12.11.3.5. Saudi Arabia Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 12.11.4. South Africa
      • 12.11.4.1. Key Country Dynamics
      • 12.11.4.2. Target Disease Prevalence
      • 12.11.4.3. Competitive Scenario
      • 12.11.4.4. Regulatory Framework
      • 12.11.4.5. South Africa Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 12.11.5. UAE
      • 12.11.5.1. Key Country Dynamics
      • 12.11.5.2. Target Disease Prevalence
      • 12.11.5.3. Competitive Scenario
      • 12.11.5.4. Regulatory Framework
      • 12.11.5.5. UAE Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 12.11.6. Kuwait
      • 12.11.6.1. Key Country Dynamics
      • 12.11.6.2. Target Disease Prevalence
      • 12.11.6.3. Competitive Scenario
      • 12.11.6.4. Regulatory Framework
      • 12.11.6.5. Kuwait Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)

Chapter 13. Competitive Landscape

  • 13.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 13.2. Company/Competition Categorization
    • 13.2.1. Innovators
  • 13.3. Vendor Landscape
    • 13.3.1. List of key distributors and channel partners
    • 13.3.2. Key customers
    • 13.3.3. Key company market share analysis, 2022
    • 13.3.4. F. Hoffmann-La Roche Ltd.
      • 13.3.4.1. Company overview
      • 13.3.4.2. Financial performance
      • 13.3.4.3. Product benchmarking
      • 13.3.4.4. Strategic initiatives
    • 13.3.5. Novartis AG
      • 13.3.5.1. Company overview
      • 13.3.5.2. Financial performance
      • 13.3.5.3. Product benchmarking
      • 13.3.5.4. Strategic initiatives
    • 13.3.6. GlaxoSmithKline plc
      • 13.3.6.1. Company overview
      • 13.3.6.2. Financial performance
      • 13.3.6.3. Product benchmarking
      • 13.3.6.4. Strategic initiatives
    • 13.3.7. Pfizer, Inc.
      • 13.3.7.1. Company overview
      • 13.3.7.2. Financial performance
      • 13.3.7.3. Product benchmarking
      • 13.3.7.4. Strategic initiatives
    • 13.3.8. Merck & Co., Inc.
      • 13.3.8.1. Company overview
      • 13.3.8.2. Financial performance
      • 13.3.8.3. Product benchmarking
      • 13.3.8.4. Strategic initiatives
    • 13.3.9. AstraZeneca
      • 13.3.9.1. Company overview
      • 13.3.9.2. Financial performance
      • 13.3.9.3. Product benchmarking
      • 13.3.9.4. Strategic initiatives
    • 13.3.10. Johnson & Johnson Services, Inc.
      • 13.3.10.1. Company overview
      • 13.3.10.2. Financial performance
      • 13.3.10.3. Product benchmarking
      • 13.3.10.4. Strategic initiatives
    • 13.3.11. Sanofi SA
      • 13.3.11.1. Company overview
      • 13.3.11.2. Financial performance
      • 13.3.11.3. Product benchmarking
      • 13.3.11.4. Strategic initiatives
    • 13.3.12. Eli Lilly and Company
      • 13.3.12.1. Company overview
      • 13.3.12.2. Financial performance
      • 13.3.12.3. Product benchmarking
      • 13.3.12.4. Strategic initiatives
    • 13.3.13. AbbVie, Inc.
      • 13.3.13.1. Company overview
      • 13.3.13.2. Financial performance
      • 13.3.13.3. Product benchmarking
      • 13.3.13.4. Strategic initiatives
    • 13.3.14. Thermo Fisher Scientific, Inc.
      • 13.3.14.1. Company overview
      • 13.3.14.2. Financial performance
      • 13.3.14.3. Product benchmarking
      • 13.3.14.4. Strategic initiatives
    • 13.3.15. Wuxi Apptec
      • 13.3.15.1. Company overview
      • 13.3.15.2. Financial performance
      • 13.3.15.3. Product benchmarking
      • 13.3.15.4. Strategic initiatives
    • 13.3.16. Samsung Biologics
      • 13.3.16.1. Company overview
      • 13.3.16.2. Financial performance
      • 13.3.16.3. Product benchmarking
      • 13.3.16.4. Strategic initiatives
    • 13.3.17. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
      • 13.3.17.1. Company overview
      • 13.3.17.2. Financial performance
      • 13.3.17.3. Product benchmarking
      • 13.3.17.4. Strategic initiatives
    • 13.3.18. Lonza
      • 13.3.18.1. Company overview
      • 13.3.18.2. Financial performance
      • 13.3.18.3. Product benchmarking
      • 13.3.18.4. Strategic initiatives
    • 13.3.19. Catalent Pharma Solutions
      • 13.3.19.1. Company overview
      • 13.3.19.2. Financial performance
      • 13.3.19.3. Product benchmarking
      • 13.3.19.4. Strategic initiatives
    • 13.3.20. Jubilant Pharmova Limited
      • 13.3.20.1. Company overview
      • 13.3.20.2. Financial performance
      • 13.3.20.3. Product benchmarking
      • 13.3.20.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 Global pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
  • Table 3 Global pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
  • Table 4 Global pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
  • Table 5 Global pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 6 Global pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
  • Table 7 Global pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
  • Table 8 Global pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
  • Table 9 Global pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
  • Table 10 Global pharmaceutical manufacturing market, by region, 2018 - 2030 (USD Billion)
  • Table 11 North America pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
  • Table 12 North America pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
  • Table 13 North America pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
  • Table 14 North America pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 15 North America pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
  • Table 16 North America pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
  • Table 17 North America pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
  • Table 18 North America pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
  • Table 19 U.S. pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
  • Table 20 U.S. pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
  • Table 21 U.S. pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
  • Table 22 U.S. pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 23 U.S. pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
  • Table 24 U.S. pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
  • Table 25 U.S. pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
  • Table 26 U.S. pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
  • Table 27 Canada pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
  • Table 28 Canada pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
  • Table 29 Canada pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
  • Table 30 Canada pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 31 Canada pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
  • Table 32 Canada pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
  • Table 33 Canada pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
  • Table 34 Canada pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
  • Table 35 Europe pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
  • Table 36 Europe pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
  • Table 37 Europe pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
  • Table 38 Europe pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 39 Europe pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
  • Table 40 Europe pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
  • Table 41 Europe pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
  • Table 42 Europe pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
  • Table 43 Germany pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
  • Table 44 Germany pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
  • Table 45 Germany pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
  • Table 46 Germany pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 47 Germany pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
  • Table 48 Germany pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
  • Table 49 Germany pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
  • Table 50 Germany pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
  • Table 51 UK pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
  • Table 52 UK pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
  • Table 53 UK pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
  • Table 54 UK pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 55 UK pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
  • Table 56 UK pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
  • Table 57 UK pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
  • Table 58 UK pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
  • Table 59 France pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
  • Table 60 France pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
  • Table 61 France pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
  • Table 62 France pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 63 France pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
  • Table 64 France pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
  • Table 65 France pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
  • Table 66 France pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
  • Table 67 Italy pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
  • Table 68 Italy pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
  • Table 69 Italy pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
  • Table 70 Italy pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 71 Italy pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
  • Table 72 Italy pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
  • Table 73 Italy pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
  • Table 74 Italy pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
  • Table 75 Spain pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
  • Table 76 Spain pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
  • Table 77 Spain pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
  • Table 78 Spain pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 79 Spain pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
  • Table 80 Spain pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
  • Table 81 Spain pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
  • Table 82 Spain pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
  • Table 83 Sweden pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
  • Table 84 Sweden pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
  • Table 85 Sweden pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
  • Table 86 Sweden pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 87 Sweden pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
  • Table 88 Sweden pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
  • Table 89 Sweden pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
  • Table 90 Sweden pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
  • Table 91 Norway pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
  • Table 92 Norway pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
  • Table 93 Norway pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
  • Table 94 Norway pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 95 Norway pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
  • Table 96 Norway pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
  • Table 97 Norway pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
  • Table 98 Norway pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
  • Table 99 Denmark pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
  • Table 100 Denmark pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
  • Table 101 Denmark pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
  • Table 102 Denmark pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 103 Denmark pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
  • Table 104 Denmark pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
  • Table 105 Denmark pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
  • Table 106 Denmark pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
  • Table 107 Asia Pacific pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
  • Table 108 Asia Pacific pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
  • Table 109 Asia Pacific pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
  • Table 110 Asia Pacific pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 111 Asia Pacific pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
  • Table 112 Asia Pacific pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
  • Table 113 Asia Pacific pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
  • Table 114 Asia Pacific pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
  • Table 115 China pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
  • Table 116 China pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
  • Table 117 China pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
  • Table 118 China pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 119 China pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
  • Table 120 China pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
  • Table 121 China pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
  • Table 122 China pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
  • Table 123 Japan pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
  • Table 124 Japan pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
  • Table 125 Japan pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
  • Table 126 Japan pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 127 Japan pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
  • Table 128 Japan pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
  • Table 129 Japan pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
  • Table 130 Japan pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
  • Table 131 India pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
  • Table 132 India pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
  • Table 133 India pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
  • Table 134 India pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 135 India pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
  • Table 136 India pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
  • Table 137 India pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
  • Table 138 India pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
  • Table 139 Thailand pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
  • Table 140 Thailand pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
  • Table 141 Thailand pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
  • Table 142 Thailand pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 143 Thailand pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
  • Table 144 Thailand pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
  • Table 145 Thailand pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
  • Table 146 Thailand pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
  • Table 147 South Korea pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
  • Table 148 South Korea pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
  • Table 149 South Korea pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
  • Table 150 South Korea pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 151 South Korea pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
  • Table 152 South Korea pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
  • Table 153 South Korea pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
  • Table 154 South Korea pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
  • Table 155 Australia pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
  • Table 156 Australia pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
  • Table 157 Australia pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
  • Table 158 Australia pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 159 Australia pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
  • Table 160 Australia pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
  • Table 161 Australia pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
  • Table 162 Australia pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
  • Table 163 Latin America pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
  • Table 164 Latin America pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
  • Table 165 Latin America pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
  • Table 166 Latin America pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 167 Latin America pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
  • Table 168 Latin America pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
  • Table 169 Latin America pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
  • Table 170 Latin America pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
  • Table 171 Brazil pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
  • Table 172 Brazil pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
  • Table 173 Brazil pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
  • Table 174 Brazil pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 175 Brazil pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
  • Table 176 Brazil pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
  • Table 177 Brazil pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
  • Table 178 Brazil pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
  • Table 179 Mexico pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
  • Table 180 Mexico pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
  • Table 181 Mexico pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
  • Table 182 Mexico pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 183 Mexico pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
  • Table 184 Mexico pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
  • Table 185 Mexico pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
  • Table 186 Mexico pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
  • Table 187 Argentina pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
  • Table 188 Argentina pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
  • Table 189 Argentina pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
  • Table 190 Argentina pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 191 Argentina pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
  • Table 192 Argentina pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
  • Table 193 Argentina pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
  • Table 194 Argentina pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
  • Table 195 Middle East and Africa pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
  • Table 196 Middle East and Africa pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
  • Table 197 Middle East and Africa pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
  • Table 198 Middle East and Africa pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 199 Middle East and Africa pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
  • Table 200 Middle East and Africa pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
  • Table 201 Middle East and Africa pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
  • Table 202 Middle East and Africa pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
  • Table 203 South Africa pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
  • Table 204 South Africa pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
  • Table 205 South Africa pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
  • Table 206 South Africa pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 207 South Africa pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
  • Table 208 South Africa pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
  • Table 209 South Africa pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
  • Table 210 South Africa pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
  • Table 211 Saudi Arabia pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
  • Table 212 Saudi Arabia pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
  • Table 213 Saudi Arabia pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
  • Table 214 Saudi Arabia pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 215 Saudi Arabia pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
  • Table 216 Saudi Arabia pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
  • Table 217 Saudi Arabia pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
  • Table 218 Saudi Arabia pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
  • Table 219 UAE pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
  • Table 220 UAE pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
  • Table 221 UAE pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
  • Table 222 UAE pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 223 UAE pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
  • Table 224 UAE pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
  • Table 225 UAE pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
  • Table 226 UAE pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
  • Table 227 Kuwait pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
  • Table 228 Kuwait pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
  • Table 229 Kuwait pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
  • Table 230 Kuwait pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
  • Table 231 Kuwait pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
  • Table 232 Kuwait pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
  • Table 233 Kuwait pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
  • Table 234 Kuwait pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Pharmaceutical manufacturing: market outlook
  • Fig. 9 Pharmaceutical manufacturing competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Pharmaceutical manufacturing market driver impact
  • Fig. 15 Pharmaceutical manufacturing market restraint impact
  • Fig. 16 Pharmaceutical manufacturing market strategic initiatives analysis
  • Fig. 17 Pharmaceutical manufacturing market: molecule type movement analysis
  • Fig. 18 Pharmaceutical manufacturing market: molecule type outlook and key takeaways
  • Fig. 19 Large molecules market estimates and forecast, 2018 - 2030
  • Fig. 20 Monoclonal Antibodies market estimates and forecast, 2018 - 2030
  • Fig. 21 Vaccines market estimates and forecast, 2018 - 2030
  • Fig. 22 Cell & Gene Therapy market estimates and forecast, 2018 - 2030
  • Fig. 23 Others market estimates and forecast, 2018 - 2030
  • Fig. 24 Small molecules market estimates and forecast, 2018 - 2030
  • Fig. 25 Pharmaceutical manufacturing market: drug development type movement analysis
  • Fig. 26 Pharmaceutical manufacturing market: drug development type outlook and key takeaways
  • Fig. 27 Outsource market estimates and forecast, 2018 - 2030
  • Fig. 28 In-house market estimates and forecast, 2018 - 2030
  • Fig. 29 Pharmaceutical manufacturing market: formulation movement analysis
  • Fig. 30 Pharmaceutical manufacturing market: formulation outlook and key takeaways
  • Fig. 31 Tablets market estimates and forecast, 2018 - 2030
  • Fig. 32 Capsules market estimates and forecast, 2018 - 2030
  • Fig. 33 Injectable market estimates and forecast, 2018 - 2030
  • Fig. 34 Sprays market estimates and forecast, 2018 - 2030
  • Fig. 35 Suspensions market estimates and forecast, 2018 - 2030
  • Fig. 36 Powders market estimates and forecast, 2018 - 2030
  • Fig. 37 Others market estimates and forecast, 2018 - 2030
  • Fig. 38 Pharmaceutical manufacturing market: route of administration movement analysis
  • Fig. 39 Pharmaceutical manufacturing market: route of administration outlook and key takeaways
  • Fig. 40 Oral market estimates and forecast, 2018 - 2030
  • Fig. 41 Topical market estimates and forecast, 2018 - 2030
  • Fig. 42 Parenteral market estimates and forecast, 2018 - 2030
  • Fig. 43 Inhalation market estimates and forecast, 2018 - 2030
  • Fig. 44 Others market estimates and forecast, 2018 - 2030
  • Fig. 45 Pharmaceutical manufacturing market: Therapy area movement analysis
  • Fig. 46 Pharmaceutical manufacturing market: Therapy Area outlook and key takeaways
  • Fig. 47 CVDs market estimates and forecast, 2018 - 2030
  • Fig. 48 Pain market estimates and forecast, 2018 - 2030
  • Fig. 49 Diabetes management market estimates and forecast, 2018 - 2030
  • Fig. 50 Cancer market estimates and forecast, 2018 - 2030
  • Fig. 51 Respiratory diseases market estimates and forecast, 2018 - 2030
  • Fig. 52 Others market estimates and forecast, 2018 - 2030
  • Fig. 53 Pharmaceutical manufacturing market: prescription movement analysis
  • Fig. 54 Pharmaceutical manufacturing market: prescription outlook and key takeaways
  • Fig. 55 Prescription medicines market estimates and forecast, 2018 - 2030
  • Fig. 56 Over-the-counter medicines market estimates and forecast, 2018 - 2030
  • Fig. 57 Pharmaceutical manufacturing market: age-group movement analysis
  • Fig. 58 Pharmaceutical manufacturing market: age-group outlook and key takeaways
  • Fig. 59 Children & Adolescents market estimates and forecast, 2018 - 2030
  • Fig. 60 Adults market estimates and forecast, 2018 - 2030
  • Fig. 61 Geriatric market estimates and forecast, 2018 - 2030
  • Fig. 62 Pharmaceutical manufacturing market: sales channel movement analysis
  • Fig. 63 Pharmaceutical manufacturing market: sales channel outlook and key takeaways
  • Fig. 64 Retail market estimates and forecast, 2018 - 2030
  • Fig. 65 Non-Retail market estimates and forecast, 2018 - 2030
  • Fig. 66 Global Pharmaceutical manufacturing market: regional movement analysis
  • Fig. 67 Global Pharmaceutical manufacturing market: regional outlook and key takeaways
  • Fig. 68 Global market share and leading players
  • Fig. 69 North America market share and leading players
  • Fig. 70 Europe market share and leading players
  • Fig. 71 Asia Pacific market share and leading players
  • Fig. 72 Latin America market share and leading players
  • Fig. 73 Middle East & Africa market share and leading players
  • Fig. 74 North America: SWOT
  • Fig. 75 Europe SWOT
  • Fig. 76 Asia Pacific SWOT
  • Fig. 77 Latin America SWOT
  • Fig. 78 MEA SWOT
  • Fig. 79 North America, by country
  • Fig. 80 North America
  • Fig. 81 North America market estimates and forecast, 2018 - 2030
  • Fig. 82 U.S. Key Country Dynamics
  • Fig. 83 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 84 Canada Key Country Dynamics
  • Fig. 85 Canada market estimates and forecast, 2018 - 2030
  • Fig. 86 Europe
  • Fig. 87 Europe. market estimates and forecast, 2018 - 2030
  • Fig. 88 UK Key Country Dynamics
  • Fig. 89 UK market estimates and forecast, 2018 - 2030
  • Fig. 90 Germany Key Country Dynamics
  • Fig. 91 Germany market estimates and forecast, 2018 - 2030
  • Fig. 92 France Key Country Dynamics
  • Fig. 93 France market estimates and forecast, 2018 - 2030
  • Fig. 94 Italy Key Country Dynamics
  • Fig. 95 Italy market estimates and forecast, 2018 - 2030
  • Fig. 96 Spain Key Country Dynamics
  • Fig. 97 Spain market estimates and forecast, 2018 - 2030
  • Fig. 98 Sweden Key Country Dynamics
  • Fig. 99 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 100 Norway Key Country Dynamics
  • Fig. 101 Norway market estimates and forecast, 2018 - 2030
  • Fig. 102 Denmark Key Country Dynamics
  • Fig. 103 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 104 Asia Pacific Key Country Dynamics
  • Fig. 105 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 106 China Key Country Dynamics
  • Fig. 107 China market estimates and forecast, 2018 - 2030
  • Fig. 108 Japan Key Country Dynamics
  • Fig. 109 Japan market estimates and forecast, 2018 - 2030
  • Fig. 110 India Key Country Dynamics
  • Fig. 111 India market estimates and forecast, 2018 - 2030
  • Fig. 112 Australia Key Country Dynamics
  • Fig. 113 Australia market estimates and forecast, 2018 - 2030
  • Fig. 114 Thailand Key Country Dynamics
  • Fig. 115 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 116 South Korea Key Country Dynamics
  • Fig. 117 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 118 Latin America
  • Fig. 119 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 120 Brazil Key Country Dynamics
  • Fig. 121 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 122 Mexico Key Country Dynamics
  • Fig. 123 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 124 Argentina Key Country Dynamics
  • Fig. 125 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 126 Middle East and Africa
  • Fig. 127 Middle East and Africa. market estimates and forecast, 2018 - 2030
  • Fig. 128 Saudi Arabia Key Country Dynamics
  • Fig. 129 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 130 South Africa Key Country Dynamics
  • Fig. 131 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 132 UAE Key Country Dynamics
  • Fig. 133 UAE market estimates and forecast, 2018 - 2030
  • Fig. 134 Kuwait Key Country Dynamics
  • Fig. 135 Kuwait market estimates and forecast, 2018 - 2030
  • Fig. 136 Participant categorization - Pharmaceutical manufacturing market
  • Fig. 137 Market share of key market players - Pharmaceutical manufacturing market